Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
51 participants
OBSERVATIONAL
2021-06-02
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. investigate the factors on antibody titer.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Antibodies Responses to COVID-19 Infection in Hospitalized Patients
NCT04520880
Antibodies and Immunity After Vaccination of Recovered Patients With COVID-19 and Long COVID-19 Symptoms
NCT05484700
Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
NCT04543006
COVID-19 Antibodies Among Healthcare Workers
NCT04425889
COVID-19 Antibody and Reinfection Study
NCT05365750
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. investigate the factors on antibody titer at 2 month after vaccination 1) potential factors: age, sex, body weight, height, use of medication, use of antipyretics (NSAID or tyrenol), side effect of COVID-19 vaccination 2) correlation between antibody titer and potential factors
3. Compare 4 diagnostic ELISA kit at 2 month after vaccination 1) measure neutralizung antibody using ELISA kits from 4 different companies 2) investigate correlation coefficient of antibody titer between companies
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
COVID-19 neutralizing antibody
This study enrolled persons already who received COVID-19 vaccination under government policy.
1. We collect 5mL blood at 2, 4, 6, 9, 12 months after COVID-19 vaccination
2. isolate serum and store in -80 degree deep freezer
3. measure neutralizing Antibody
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 20-60 years
* sign the agreement of study
Exclusion Criteria
20 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kyungpook National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Su Youn Nam
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Su Youn Nam, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Kyungpook National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kyungpook National University Hospital
Daegu, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Nam SY, Jeon SW, Jung DK, Heo SJ. Body Weight is Inversely Associated with Anti-SARS-CoV-2 Antibody Levels after BNT162b2 mRNA Vaccination in Young and Middle Aged Adults. Infect Chemother. 2022 Sep;54(3):504-516. doi: 10.3947/ic.2022.0089.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KNUCH-2021005-001-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.